GNH USA

Europe — EMA

Norgestimaat/Ethinylestradiol Xiromed (Ethinylestradiol, Norgestimate)

GNH USA supplies Norgestimaat/Ethinylestradiol Xiromed (Ethinylestradiol/Norgestimate), an oral contraceptive for pregnancy. Request a quote for supply.

Ethinylestradiol, Norgestimate

Request sourcing

1
Pack/s

What is Ethinylestradiol, Norgestimate?

Ethinylestradiol, the active ingredient in Norgestimaat/Ethinylestradiol Xiromed, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy in women of reproductive age. Norgestimate, the second active ingredient, works together with ethinylestradiol to provide reliable hormonal birth control.

GNH USA supplies Norgestimaat/Ethinylestradiol Xiromed as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

What is Ethinylestradiol, Norgestimate used for?

Norgestimaat/Ethinylestradiol Xiromed is a combined oral contraceptive that acts on the hormonal regulation of the menstrual cycle to prevent pregnancy. - Contraception: prevents pregnancy by suppressing ovulation and altering cervical mucus. - Menstrual cycle regulation: helps achieve more predictable bleeding patterns. - Reduction of functional ovarian cysts: decreases the formation of benign ovarian cysts.

What are the side effects of Ethinylestradiol, Norgestimate?

Norgestimaat/Ethinylestradiol Xiromed may cause a range of adverse reactions.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: swelling or discomfort of the breasts. - Weight gain: modest increase in body weight. - Mood changes: irritability or emotional fluctuations. - Spotting: light bleeding between periods.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in deep veins. - Pulmonary embolism: clot migration to the lungs. - Stroke: interruption of cerebral blood flow. - Myocardial infarction: heart attack due to coronary blockage. - Severe allergic reaction: rash, swelling, or anaphylaxis. - Liver dysfunction: jaundice or abnormal liver enzymes.

What precautions apply to Ethinylestradiol, Norgestimate?

Before prescribing Norgestimaat/Ethinylestradiol Xiromed, clinicians should evaluate patient history and risk factors. - Contraindications: Do not use in women with a history of thromboembolic disorders, estrogen‑dependent tumors, or active liver disease. - Smoking: Avoid in women over 35 who smoke, due to increased cardiovascular risk. - Medical history: Assess for hypertension, diabetes, or migraine with aura. - Medication adherence: Take the tablet at the same time each day to maintain efficacy. - Store at ambient temperature: keep in the original pack, protect from moisture and light.

What does Ethinylestradiol, Norgestimate interact with?

Norgestimaat/Ethinylestradiol Xiromed can interact with several medicines, affecting its effectiveness or safety.

Major Interactions (Avoid): - Antiepileptics (carbamazepine, phenytoin): reduce contraceptive efficacy. - Antibiotics (rifampin, griseofulvin): may lower hormone levels. - St. John’s wort: decreases contraceptive effectiveness.

Moderate Interactions (Monitor Closely): - Antifungals (ketoconazole): may increase hormone concentrations. - Antidepressants (SSRIs): may enhance mood‑related side effects. - Diuretics (spironolactone): may affect fluid balance and blood pressure.

Frequently asked questions

What is Norgestimaat/Ethinylestradiol Xiromed used for?+
Norgestimaat/Ethinylestradiol Xiromed is a combined oral contraceptive containing ethinylestradiol and norgestimate. It is prescribed to prevent pregnancy in women of reproductive age by inhibiting ovulation and modifying cervical mucus and the endometrial lining.
How does ethinylestradiol work in this product?+
Ethinylestradiol is a synthetic estrogen that binds to estrogen receptors, providing negative feedback to the hypothalamus and pituitary gland. This feedback reduces the secretion of luteinizing hormone (LH) and follicle‑stimulating hormone (FSH), thereby suppressing ovulation and contributing to the contraceptive effect.
What is the usual dose of Norgestimaat/Ethinylestradiol Xiromed?+
The specific dosing regimen is determined by the prescribing clinician. Typically, the product is taken as one tablet daily for 21 consecutive days followed by a hormone‑free interval, but the exact schedule should follow the prescriber’s instructions.
Is Norgestimaat/Ethinylestradiol Xiromed safe during pregnancy or breastfeeding?+
The medication is contraindicated during pregnancy and should be stopped if pregnancy occurs. Limited safety data exist for breastfeeding; most guidelines advise caution and suggest alternative contraception for nursing mothers.
How do I order Norgestimaat/Ethinylestradiol Xiromed from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com, specifying the required quantity. GNH USA works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.
How does this product compare with other combined oral contraceptives?+
Norgestimaat/Ethinylestradiol Xiromed contains the progestin norgestimate, which is associated with a lower incidence of androgenic side effects such as acne compared with some older progestins. Its efficacy in preventing pregnancy is comparable to other FDA‑approved combined pills, while the side‑effect profile may differ slightly based on individual tolerance.
What are the storage and handling requirements for this tablet?+
Store the tablets at ambient temperature below 25 °C. Keep them in the original packaging, protect from moisture and direct light, and ensure the container is tightly closed to maintain product stability.
How is Norgestimaat/Ethinylestradiol Xiromed administered?+
The medication is taken orally with water. For optimal effectiveness, it should be taken at the same time each day, preferably with or without food, as directed by the healthcare provider.
What are the most serious risks associated with this contraceptive?+
Serious risks include thromboembolic events such as deep‑vein thrombosis, pulmonary embolism, stroke, and myocardial infarction. Rare but severe reactions can involve severe allergic responses and liver dysfunction. Patients should seek immediate medical attention if they experience symptoms like sudden chest pain, shortness of breath, severe headache, or jaundice.
Who should not use Norgestimaat/Ethinylestradiol Xiromed?+
Women with a history of blood‑clotting disorders, estrogen‑dependent tumors, uncontrolled hypertension, severe liver disease, or who are pregnant or breastfeeding should avoid this product. Additionally, smokers over 35 years of age are advised not to use combined oral contraceptives due to increased cardiovascular risk.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.
Send a sourcing enquiry for this product →

Product details

Drug
Ethinylestradiol, Norgestimate
Route
Oral Use
Manufacturer
Medical Valley Invest Ab
Origin
EU

Related products

Amicette

Amicette

Ethinylestradiol, Norgestimate

Aristo Pharma Gmbh (Art 57)
EU
Amorina

Amorina

Ethinylestradiol, Norgestimate

Effik
EU
Amorina

Amorina

Ethinylestradiol, Norgestimate

Effik
EU
Amorina

Amorina

Ethinylestradiol, Norgestimate

Effik
EU